Financial News
Latest News about ACAD
Recent news which mentions ACAD
From Benzinga
Analysts Say Acadia's Negative Pain Data Increases Focus On Pimavanserin For Alzheimer's-Related Psychosis
April 19, 2022
Tickers
ACAD
From Benzinga
From Benzinga
From InvestorPlace
23 Stocks Moving in Tuesday's Pre-Market Session
April 19, 2022
From Benzinga
From Benzinga
28 Biggest Movers From Yesterday
April 12, 2022
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
April 07, 2022
From Benzinga
From Benzinga
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
April 03, 2022
From Benzinga
From InvestorPlace
From Benzinga
From Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
From Benzinga
Acadia Resubmits Pimavanserin US Application For Expanded Use In Alzheimer's Psychosis
February 16, 2022
Tickers
ACAD
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 9, 2022
February 09, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 12, 2022
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2022
January 05, 2022
From Benzinga
What 17 Analyst Ratings Have To Say About ACADIA Pharmaceuticals
January 05, 2022
Tickers
ACAD
From Benzinga
$1000 Invested In This Stock 10 Years Ago, Would Be Worth This Much
December 28, 2021
Tickers
ACAD
From Benzinga
5 Beaten Down Biotech Stocks That Could Bounce Big In 2022
December 27, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
